[HTML][HTML] Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy
Q Liu, C Guan, C Liu, H Li, J Wu, C Sun - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Triple-negative breast cancer (TNBC) is a subtype of breast cancer that is highly aggressive
and hypoxic compared with other subtypes. The role of hypoxia inducible factor 1α (HIF-1α) …
and hypoxic compared with other subtypes. The role of hypoxia inducible factor 1α (HIF-1α) …
FOXA1: a pioneer of nuclear receptor action in breast cancer
DD Seachrist, LJ Anstine, RA Keri - Cancers, 2021 - mdpi.com
Simple Summary Factors such as estrogen, progesterone, and androgen receptors, also
known as nuclear receptors, are abundantly expressed in the majority of breast cancers …
known as nuclear receptors, are abundantly expressed in the majority of breast cancers …
Crosstalk between p38 MAPK and GR Signaling
L Zeyen, OM Seternes, I Mikkola - International journal of molecular …, 2022 - mdpi.com
The p38 MAPK is a signaling pathway important for cells to respond to environmental and
intracellular stress. Upon activation, the p38 kinase phosphorylates downstream effectors …
intracellular stress. Upon activation, the p38 kinase phosphorylates downstream effectors …
Advantages and drawbacks of dexamethasone in glioblastoma multiforme
The most widespread, malignant, and deadliest type of glial tumor is glioblastoma
multiforme (GBM). Despite radiation, chemotherapy, and radical surgery, the median …
multiforme (GBM). Despite radiation, chemotherapy, and radical surgery, the median …
[HTML][HTML] HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer via PI3K/AKT/mTOR signaling
J Bai, WB Chen, XY Zhang, XN Kang, LJ Jin… - World journal of stem …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Breast cancer is a common malignant tumor that seriously threatens
women's health. Breast cancer stem cell (CSC)-like cell population may be the main factor …
women's health. Breast cancer stem cell (CSC)-like cell population may be the main factor …
Glucocorticoid receptor: a multifaceted actor in breast cancer
LM Noureddine, O Trédan, N Hussein… - International Journal of …, 2021 - mdpi.com
Breast cancer (BC) is one of the most common cancers in women worldwide. Even though
the role of estrogen receptor alpha (ERα) is extensively documented in the development of …
the role of estrogen receptor alpha (ERα) is extensively documented in the development of …
Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress
Triple-negative breast cancer (TNBC) has a poor clinical outcome, due to a lack of
actionable therapeutic targets. Herein we define lysosomal acid lipase A (LIPA) as a viable …
actionable therapeutic targets. Herein we define lysosomal acid lipase A (LIPA) as a viable …
Glucocorticoid receptors drive breast cancer cell migration and metabolic reprogramming via PDK4
Corticosteroids act on the glucocorticoid receptor (GR; NR3C1) to resolve inflammation and
are routinely prescribed to breast cancer patients undergoing chemotherapy treatment to …
are routinely prescribed to breast cancer patients undergoing chemotherapy treatment to …
Discovery of a glucocorticoid receptor (GR) activity signature using selective GR antagonism in ER-negative breast cancer
DC West, M Kocherginsky, EY Tonsing-Carter… - Clinical Cancer …, 2018 - AACR
Purpose: Although high glucocorticoid receptor (GR) expression in early-stage estrogen
receptor (ER)-negative breast cancer is associated with shortened relapse-free survival …
receptor (ER)-negative breast cancer is associated with shortened relapse-free survival …
Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression
H Butz, A Patócs - Cancer and Metastasis Reviews, 2022 - Springer
Abstract Glucocorticoids (GCs), mostly dexamethasone (dex), are routinely administered as
adjuvant therapy to manage side effects in breast cancer. However, recently, it has been …
adjuvant therapy to manage side effects in breast cancer. However, recently, it has been …